Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|August 16, 2023
Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 InhibitionSatish Kumar R Noonepalle, Scott Grindrod, Nima Aghdam, et al.
Clinical and Translational Radiation Oncology|July 3, 2025
Urethral and bladder dosimetry and urinary toxicity in prostate cancer patients undergoing SBRT with and without intra-prostatic boostNisha Bhargava, Martina Hurwitz, Josephine Levey, et al.
Prostate Cancer and Prostatic Diseases|March 30, 2024
The association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016Cooper Desmond, Sumedh Kaul, Aaron Fleishman, et al.
Frontiers in Oncology|February 13, 2016
Radiation Metabolomics: Current Status and Future DirectionsSmrithi S Menon, Medha Uppal, Subeena Randhawa, et al.
Frontiers in Oncology|February 7, 2022
Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate CancerAbigail N Pepin, Alan Zwart, Malika Danner, et al.
Radiation Oncology (London, England)|October 21, 2017
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiationMichael C Repka, Nima Aghdam, Shaan K Kataria, et al.
Cureus|April 12, 2021
Impact of Age on Patient-Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate CancerAbigail Pepin, Monica Pernia, Malika T Danner, et al.
Pageof 6